Director of AXIS Capital (NYSE: AXS) receives 1,594 share award

Rhea-AI Filing Summary

AXIS Capital Holdings director Michael Millegan reported a stock compensation grant. On January 15, 2026, he acquired 1,594 AXIS Capital common shares with a transaction code of "A," which in this context reflects an award rather than an open-market purchase. According to the footnote, these shares were issued as director’s fees using the January 15, 2026 closing price of $100.34 as the reference value, so no cash changed hands on the Form 4 (price per share is shown as zero).

Following this grant, Millegan beneficially owned 12,275 common shares of AXIS Capital Holdings Ltd., held directly. The filing reflects routine equity-based compensation for board service, not a discretionary market trade.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Millegan Michael

(Last) (First) (Middle)

C/O AXIS CAPITAL HOLDINGS LIMITED

29 RICHMOND ROAD, 3RD FLR

(Street)

PEMBROKE D0 HM 08

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AXIS CAPITAL HOLDINGS LTD [ AXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/15/2026		A		1,594	A	(1)	12,275	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Common shares issued as director's fees using January 15, 2026 closing price of $100.34.

Remarks:

	G. Christina Gray-Trefry, Attorney-in-Fact	01/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AXIS Capital (AXS) director Michael Millegan report in this Form 4?

Michael Millegan reported receiving 1,594 AXIS Capital common shares on January 15, 2026 as part of his director compensation.

Was this AXIS Capital Form 4 transaction a purchase or a stock grant?

The Form 4 shows transaction code "A" and a share price of $0.00, with a footnote explaining the shares were issued as director's fees, indicating a stock grant, not a market purchase.

What reference price was used to value the AXIS Capital director share grant?

The footnote states the common shares were issued as director's fees using the January 15, 2026 closing price of $100.34 as the reference value.

How many AXIS Capital shares does Michael Millegan own after this transaction?

After the grant of 1,594 shares, Michael Millegan beneficially owned 12,275 AXIS Capital common shares, held directly.

Is Michael Millegan a 10% owner of AXIS Capital stock?

No. The filing indicates he is a director of AXIS Capital Holdings Ltd. and not a 10% owner.

Does this AXIS Capital Form 4 involve any derivative securities?

No. The filing’s Table I reports only non-derivative common shares, and Table II for derivative securities is empty.